Cancer Treatment Reviews

Aims & Scope

Cancer Treatment Reviews Welcome to the online submission and editorial system for Cancer Treatment Reviews.

Cancer Treatment Reviews is an international journal that helps keep both the clinician and researcher abreast of developments in cancer treatment research through the publication of state-of-the-art, authoritative reviews.

Each issue provides topical reviews under the following regular sections: • comments on controversy • tumor reviews • anti-tumor treatments • new drugs • complications of treatment • general and supportive care • laboratory/clinic interface.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	10.5
2024	9.60

Journal Rank

Year	Value
2024	383

Journal Citation Indicator

Year	Value
2024	3171

SJR (SCImago Journal Rank)

Year	Value
2024	4.183

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	172

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• PI3K/Akt signalling pathway and cancer

  Citation: 1895

  Authors: Juan Ángel Fresno, Enrique, Javier, Paloma, Cristóbal, Manuel

• Metastatic bone disease: clinical features, pathophysiology and treatment strategies

  Citation: 1504

  Authors: R.E.

• Molecular mechanisms of resistance and toxicity associated with platinating agents

  Citation: 1277

  Authors: Cara A., M. Eileen

• CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy

  Citation: 1155

  Authors: Ryuma, Wu, Madiha, Alberto, Martin D, Shivani, Michelle, Hideo, Heinz-Josef

• The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer

  Citation: 1076

  Authors: Donald C.

• Osteosarcoma treatment – Where do we stand? A state of the art review

  Citation: 992

  Authors: Anja, Paul A., Ian, Heribert

• Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

  Citation: 907

  Authors: Josep, Herbert I., Alan B., David, Robert L, Regula, Olivier L

• Elevated copper and oxidative stress in cancer cells as a target for cancer treatment

  Citation: 876

  Authors: Anshul, Russell J.

• Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors

  Citation: 802

  Authors: Nithya, Razelle

• Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

  Citation: 747

  Authors: Kiran, Jeffrey D., Jim Z., Mason W., Claudie

---